OFS
MDGL icon

Orrstown Financial Services’s Madrigal Pharmaceuticals MDGL Stock Holding History

Orrstown Financial Services’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-6
Closed -$1K – 196
2014
Q2 		$1K Hold
6
– – ﹤0.01% 189
2014
Q1 		$1K Buy
+6
New +$1.18K ﹤0.01% 191

Other funds holding MDGL

CC
Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Orrstown Financial Services's MDGL Position: Q3 2014 in Review

Orrstown Financial Services sold out of Madrigal Pharmaceuticals (MDGL) in Q3 2014, closing a stake of 6 shares — an estimated $1K sold.

Orrstown Financial Services first reported a position in MDGL in Q1 2014 and held it in 2 quarters. The position peaked at $1K in Q2 2014. 92 funds tracked by Wall St. Rank hold MDGL as of Q3 2014.

  • Orrstown Financial Services reported no remaining Madrigal Pharmaceuticals position as of Q3 2014 after selling out during the quarter.
  • Orrstown Financial Services sold 6 Madrigal Pharmaceuticals shares in Q3 2014, an estimated $1K.
  • Orrstown Financial Services first reported a position in Madrigal Pharmaceuticals in Q1 2014 and held it in 2 quarters.
  • Orrstown Financial Services's Madrigal Pharmaceuticals position peaked at $1K in Q2 2014.
  • 92 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2014.

Based on Orrstown Financial Services's 13F filing for Q3 2014, filed 10 Oct 2014.